HK1070671A1 - Cotton rat lung cells for virus culture - Google Patents

Cotton rat lung cells for virus culture

Info

Publication number
HK1070671A1
HK1070671A1 HK05103598.5A HK05103598A HK1070671A1 HK 1070671 A1 HK1070671 A1 HK 1070671A1 HK 05103598 A HK05103598 A HK 05103598A HK 1070671 A1 HK1070671 A1 HK 1070671A1
Authority
HK
Hong Kong
Prior art keywords
cotton rat
lung cells
virus culture
rat lung
pathogens
Prior art date
Application number
HK05103598.5A
Other languages
English (en)
Inventor
Frederic R David
Michael E Tanner
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of HK1070671A1 publication Critical patent/HK1070671A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0688—Cells from the lungs or the respiratory tract
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK05103598.5A 2002-03-20 2005-04-27 Cotton rat lung cells for virus culture HK1070671A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36601402P 2002-03-20 2002-03-20
US10/391,498 US7906311B2 (en) 2002-03-20 2003-03-18 Cotton rat lung cells for virus culture
PCT/US2003/008418 WO2003102021A2 (en) 2002-03-20 2003-03-19 Cotton rat lung cells for virus culture

Publications (1)

Publication Number Publication Date
HK1070671A1 true HK1070671A1 (en) 2005-06-24

Family

ID=29553339

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05103598.5A HK1070671A1 (en) 2002-03-20 2005-04-27 Cotton rat lung cells for virus culture

Country Status (17)

Country Link
US (1) US7906311B2 (ru)
EP (1) EP1517987B1 (ru)
KR (1) KR20050005426A (ru)
CN (1) CN1653172A (ru)
AT (1) ATE511397T1 (ru)
AU (1) AU2003265230B8 (ru)
BR (1) BRPI0308736B1 (ru)
CA (1) CA2479747C (ru)
CY (1) CY1111775T1 (ru)
DK (1) DK1517987T3 (ru)
HK (1) HK1070671A1 (ru)
MA (1) MA27416A1 (ru)
MX (1) MXPA04009050A (ru)
PT (1) PT1517987E (ru)
RU (1) RU2376370C2 (ru)
SI (1) SI1517987T1 (ru)
WO (1) WO2003102021A2 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
MX2009007457A (es) 2007-01-12 2009-08-12 Univ Illinois Celulas que no son de mono para el desarrollo del virus del sindrome porcino reproductor y respiratorio (prrs).
RU2496870C2 (ru) * 2011-02-15 2013-10-27 Государственное научное учреждение Прикаспийский зональный научно-исследовательский ветеринарный институт Российской академии сельскохозяйственных наук Способ получения эпителиоподобных клеток легкого плода буйволицы для культивирования вирусов
CN103893750B (zh) * 2012-12-31 2015-11-25 普莱柯生物工程股份有限公司 一种抗猪伪狂犬病、猪流感疫苗组合物及其应用
CN105103464B (zh) 2013-06-05 2018-05-15 Lg电子株式会社 在无线通信系统中发送信道状态信息的方法和装置
CN103387604B (zh) * 2013-07-25 2015-04-15 中国农业科学院上海兽医研究所 鸡ibv s1蛋白的cd8+t细胞抗原表位多肽
AU2015241107B2 (en) 2014-04-03 2019-10-03 Boehringer Ingelheim Animal Health USA Inc. Porcine epidemic diarrhea virus vaccine
CN108130316A (zh) * 2018-02-09 2018-06-08 天康生物股份有限公司 猪流行性腹泻病毒及其分离方法和应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1408437A (en) 1972-10-16 1975-10-01 C Vet Ltd Vaccines
US5626851A (en) 1987-11-30 1997-05-06 The Wistar Institute Of Anatomy And Biology Rotavirus reassortant vaccine
US5151267A (en) * 1988-07-15 1992-09-29 University Of Saskatchewan Bovine herpesvirus type 1 polypeptides and vaccines
FR2693472B1 (fr) 1992-06-26 1994-12-23 Rhone Merieux Mutants du virus de la rhinotrachéite infectieuse bovine, délétés dans l'un des gènes des glycoprotéines mineures, vaccins préparés à partir de ces souches, méthodes de production et méthodes d'utilisation.
US5616326A (en) 1990-01-25 1997-04-01 The University Court Of The University Of Glasgow Recombinant canine adenovirus 2 (CAV-2)
CA2290906C (en) 1991-06-06 2003-04-01 Stichting Centraal Diergeneeskundig Instituut Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
MX9204885A (es) 1991-08-26 1994-05-31 Boehringer Animal Health Inc Composicion de vacuna que comprende virus del sindrome de infertilidad y respiratorio de los cerdos.
DE69214657T4 (de) 1991-08-26 2003-07-17 Boehringer Ingelheim Vetmed Vakzine gegen und diagnosemethode für das schweine-unfruchtbarkeits- und atmungs-syndrom (suas)
US6013638A (en) * 1991-10-02 2000-01-11 The United States Of America As Represented By The Department Of Health And Human Services Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung
JP2521226B2 (ja) 1993-01-28 1996-08-07 株式会社微生物化学研究所 犬用多種混合ワクチン
AU681874B2 (en) 1993-02-08 1997-09-11 Bayer Corporation Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines
ATE206455T1 (de) 1994-04-11 2001-10-15 Akzo Nobel Nv Europäische vakzinstämme des fortplanzungs- atmungs-syndromsvirus des schweins
DE69632658T2 (de) 1995-03-14 2005-06-09 Akzo Nobel N.V. Expression in der selben Zelle von Polypeptide vom schweinen reproduktiven und respiratorischen Syndrom
ATE274579T1 (de) * 1995-06-12 2004-09-15 Univ Kansas State Multivalenter impstoff gegen bovines coronavirus und methode zur behandlung einer infektion mit bovinem coronavirus
FR2750865B1 (fr) 1996-06-27 1998-12-04 Rhone Merieux Vaccin vivant recombinant a base d'herpesvirus canin, notamment contre la maladie de carre, la rage ou le virus parainfluenza de type 2
US5976537A (en) 1996-07-02 1999-11-02 The United States Of America As Represented By The Secretary Of Agriculture Porcine reproductive and respiratory syndrome vaccine
US6090393A (en) 1996-07-03 2000-07-18 Merial Recombinant canine adenoviruses, method for making and uses thereof
FR2751228B1 (fr) 1996-07-19 1998-11-20 Rhone Merieux Vaccin polynucleotidique bovin pour voie intradermique
FR2751224B1 (fr) 1996-07-19 1998-11-20 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
FR2751229B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
FR2751226B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies du cheval
FR2751227B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
JP2950273B2 (ja) 1997-01-27 1999-09-20 株式会社微生物化学研究所 ウシロタウイルス病ワクチン
US6368603B1 (en) 1997-03-05 2002-04-09 Merial Limited Lyme combination compositions and uses
AUPO856097A0 (en) 1997-08-14 1997-09-04 Commonwealth Scientific And Industrial Research Organisation Vector
US6391314B1 (en) 1997-10-03 2002-05-21 Merial Porcine circoviruses vaccines diagnostic reagents
US6517843B1 (en) 1999-08-31 2003-02-11 Merial Reduction of porcine circovirus-2 viral load with inactivated PCV-2
FR2781159B1 (fr) 1998-07-06 2000-10-06 Merial Sas Vaccin circovirus et parvovirus porcin
US6492343B1 (en) * 1998-04-15 2002-12-10 University Of Saskatchewan Porcine adenovirus type 3 genome
AU758604B2 (en) 1998-07-31 2003-03-27 Intervet International B.V. Attenuated equine herpesvirus
US20020037274A1 (en) * 1998-10-26 2002-03-28 Angelica Williams Single agent method for killing tumor and tumor associated endothelial cells using adenoviral mutants
NZ513289A (en) 1998-12-22 2003-04-29 Pfizer Prod Inc Infectious cDNA clone of north american procine reproductive and respiratory syndrome (PRRS) virus and uses thereof
FR2789695B1 (fr) 1999-02-11 2003-03-07 Merial Sas Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs
US6379676B2 (en) 1999-03-10 2002-04-30 Anitox Corporation Enhancing immune response in animals
AU4220600A (en) 1999-04-09 2000-11-14 Schering-Plough Ltd Recombinant and mutant adenoviruses derived of bovine adenovirus type1
US6497883B1 (en) 1999-06-10 2002-12-24 Merial Porcine circovirus recombinant poxvirus vaccine
ES2170622B1 (es) 1999-12-03 2004-05-16 Consejo Superior De Investigaciones Cientificas Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
EP1129722A1 (en) 2000-02-17 2001-09-05 Boehringer Ingelheim Vetmedica Gmbh gM-negative EHV-mutants
WO2001083737A2 (en) 2000-05-03 2001-11-08 University Of Guelph Porcine adenovirus type 5 vector and vaccine
CA2409874A1 (en) 2000-05-24 2001-11-29 Merial Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine
EP1383918A4 (en) * 2001-04-03 2005-01-05 Biosynexus Inc ANIMAL MODEL FOR DARMPATHOGENE

Also Published As

Publication number Publication date
DK1517987T3 (da) 2011-07-11
MA27416A1 (fr) 2005-07-01
WO2003102021A2 (en) 2003-12-11
US7906311B2 (en) 2011-03-15
RU2376370C2 (ru) 2009-12-20
BRPI0308736B1 (pt) 2016-04-05
RU2004130864A (ru) 2005-05-10
CA2479747C (en) 2010-10-19
AU2003265230A1 (en) 2003-12-19
AU2003265230B8 (en) 2009-06-18
AU2003265230B2 (en) 2009-02-19
CY1111775T1 (el) 2015-10-07
CA2479747A1 (en) 2003-12-11
EP1517987A2 (en) 2005-03-30
EP1517987B1 (en) 2011-06-01
MXPA04009050A (es) 2005-06-08
US20030219460A1 (en) 2003-11-27
SI1517987T1 (sl) 2011-09-30
KR20050005426A (ko) 2005-01-13
ATE511397T1 (de) 2011-06-15
CN1653172A (zh) 2005-08-10
WO2003102021A3 (en) 2004-09-30
PT1517987E (pt) 2011-07-12
BR0308736A (pt) 2005-08-16
EP1517987A4 (en) 2006-12-20

Similar Documents

Publication Publication Date Title
CY1111775T1 (el) Πνευμονικα κυτταρα βαμβακοαρουραιου για καλλιεργεια ιου
HK1062029A1 (en) Multiplication of viruses in a cell culture
MX2007005132A (es) Medios libres de proteina animal para cultivo de celulas.
HK1080507A1 (en) Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
MY146518A (en) Methods to culture circovirus.
MX2007015217A (es) Sistema automatizado de terapia mediante celulas.
UA92157C2 (ru) Способ продуцирования гормона роста
SG152273A1 (en) Pdx1 expressing endoderm
WO2005104706A3 (en) Stirred-tank reactor system
WO2006070370A3 (en) Stem cells culture systems
WO2007051038A3 (en) Pdx1-expressing dorsal and ventral foregut endoderm
HK1075467A1 (en) Process for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process
AU2003285172A1 (en) Human embryonic stem cell cultures, and compositions and methods for growing same
EP3486314A3 (en) Placental stem cell populations
EP1619245A4 (en) METHOD FOR THE PRODUCTION OF CORTICULAR CELLS FOR TRANSPLANTATION
TW200617165A (en) Process for preparing a conditioned medium of astrocyte-like cells
DE602006014534D1 (de) Herstellung und verwendung von basalmembranpartikeln
WO2004033616A8 (de) Einrichtung zur kultivierung von zellen, insbesondere menschlicher oder tierischer zellen
AU2001278700A1 (en) Method of culturing human chondrocytes
WO2003100010A3 (en) Cytokine-free growth and maintenance of progenitor cells
DK1238057T3 (da) Fremgangsmåde til produktion af vedhæftende dyreceller
AU8478601A (en) Methods for culturing human lung mast cells and uses thereof
AU2003242533A1 (en) Glutamine-free medium
UA36386A (ru) Камера для культивирования клеток
UA34226U (ru) Способ определения токсигенности холерных вибрионов

Legal Events

Date Code Title Description
AM Amended specification (according sect 146 of patent law)

Free format text: ADDITION OF PRIORITY CLAIM: 18/03/2003 US 391498

Effective date: 20111017

PE Patent expired

Effective date: 20230318